Join Now

Author Archives: admin

Utah Leads Together Accountability Framework

By admin | Published September 11, 2020

This Utah Leads Together Accountability Framework presents Utah’s strategic, data-driven, and concentrated effort to protect the lives and livelihoods of all Utahns. The framework includes a clear mission, two major goals, six supporting objectives, and a variety of lead measures and strategies. A scorecard of measurable targets motivates progress. Together with a refined accountability structure, […]

Posted in COVID-19 Updates | Leave a comment

Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases

By admin | Published September 11, 2020

By Chris Gibson, PhD via Recursion – Drug discovery partnership and equity investment led by Leaps by Bayer in Series D financing round – Digitally-powered drug discovery to address fibrotic diseases with previously undiscovered mechanisms and to deliver novel therapies to patients faster Berlin, Germany and Salt Lake City, USA, September 9, 2020 – Bayer and […]

Posted in Industry News, Life Sciences Industry News | Leave a comment

HHS Move Upends FDA Role in Laboratory-Developed Test Regulation

By admin | Published August 28, 2020

By Adam Bonislawski for GenomeWeb NEW YORK – In a surprise move, the US Department of Health and Human Services said on Wednesday that it had determined the Food and Drug Administration would not require premarket review of laboratory-developed tests without notice-and-comment rulemaking. The announcement, which took many in the lab industry aback, appeared to […]

Posted in COVID-19 Updates, HHS/FDA & Other Regulatory | Leave a comment

Clene Nanomedicine Raises Series D Financing of $42.5 Million

By admin | Published August 28, 2020

SALT LAKE CITY, August 26, 2020 – Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced that it has secured $42.5 million in a Series D financing. The round was led by SymBiosis II, LLC, a biotech-focused investment vehicle. Participants in the round included existing investors, as well as new institutional investors from South Korea […]

Posted in Policy News | Leave a comment

BioUtah and Utah Biotech/Biopharma Companies Raise Concerns About Impact of Trump’s “Most-Favored-Nation” Drug Pricing Order on Innovation

By admin | Published August 19, 2020

BioUtah, along with 10 Utah biotech and biopharma companies, have sent letters to Utah’s U.S. Senators and Representatives urging opposition to the President’s directive to impose “most-favored nation” pricing on Medicare Part B drugs. The letter notes that if the executive order moves forward, investment dollars for Utah’s smaller drug discovery companies could dry up […]

Posted in Industry News, Policy News | Leave a comment

2020 IPO Comeback Webcast Series from PwC

By admin | Published August 13, 2020

After IPO issuances came to a near-halt in late Q1 and early Q2, the window reopened wide this summer, when much-needed liquidity infused the markets and led to one of the strongest months for IPOs in 13 years. Join us for a two-part executive webcast series on the novel challenges of capital raising during a […]

Posted in Events | Leave a comment

COVID-19 Grant Relief Program Updates as of 8/12/2020 9:20 am

By admin | Published August 13, 2020

Shop In Utah: $35M (+ $10M added from ComRent) Opened Monday, July 27 – closed August 7, 2020, at 1:30 p.m. Shop in Utah number of applications received: 872 Shop in Utah total award amount requested: $42,344,434 Shop in Utah number of awards: 653 Shop in Utah total award amount: $26,790,444 Average award amount: $41,023 […]

Posted in Funding | Leave a comment

BioUtah Statement on Launch of Altitude Lab, Largest Life Sciences Incubator in Utah

By admin | Published August 12, 2020

Recursion and University of Utah found incubator to propel new generation of life sciences in the region August 12, 2020 04:18 PM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–BioUtah President and CEO, Kelvyn Cullimore, issued the following statement following the announcement of the opening of Altitude Lab. “This is truly a life sciences milestone in […]

Posted in BioUtah News, Industry News, Life Sciences Industry News | Leave a comment

BIO Investor Forum Digital

By admin | Published August 6, 2020

BioUtah members are eligible for an exclusive discounted rate on our premiere BIO Investor Forum Digital registration package! HOW IT WORKS: Anyone can fill out the form to request a 20% discount. They will receive a discount code via email upon  completing the form. BIO will honor this code and rate up until showtime. Codes […]

Posted in Events | Leave a comment

BIO Investor Forum Digital

By admin | Published August 3, 2020

Company Presentations are an integral programming element at BIO Investor Forum Digital that allow companies to discuss their pipeline, R&D activities, and future fundraising goals to this exclusive audience of investors and collaboration partners. Learn more and apply to present here.

Posted in Events | Leave a comment

RAPS Convergence 2020 — live online!

By admin | Published August 3, 2020

Convergence is the largest annual gathering of regulatory professionals, regulators, scientists, and innovators from around the world and the only US event that is exclusively dedicated to the regulatory profession. And this year, the community will converge online with two virtual registration options that will allow attendees to experience Convergence live online from the safety […]

Posted in Events, Policy News | Leave a comment

Global Value-Based Healthcare

By admin | Published August 3, 2020

Take a quick lunch break to hear from Mike Leavitt (former U.S. Secretary of Health and Human Services and former Utah Governor) as he takes 20 minutes to discuss “Public Health: The Invisible Ingredient in Value-Based Care” in this free webinar. Learn more and register here.

Posted in Events | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members